Atlas Trials

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Clinical trial NCT00553683 · UNKNOWN

Trial details

NCT number
NCT00553683
Sponsor
Rutgers, The State University of New Jersey
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast CancerColorectal CancerGastric CancerLiver CancerMelanoma (Skin)Metastatic CancerOvarian CancerPancreatic Cancer
Start date
2007-10-01
Primary completion
2014-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.